PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
21-Nov-2024 EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR 49.3 million to EUR 300.3 million, which corresponds to 70.14 euros per share. The equity ratio rises to 94.85%. MPH Health Care AG
21-Nov-2024 NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System Olympus
21-Nov-2024 Xlife Sciences AG Announces the listing of FUSE-AI GmbH on the London Stock Exchange in the First Half of 2025 Xlife Sciences AG
20-Nov-2024 Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies AccessWire
20-Nov-2024 Dr. Bill Releford and Los Angeles Rams Partner to Empower Community Health and Wellness AccessWire
20-Nov-2024 Model N Introduces GenAI and Intelligent Data Innovations to Market-Leading Revenue Optimization and Compliance Offering Model N
20-Nov-2024 Retinal Scanning Startup DeepEyeVision, Inc. is First in the World to Receive Validation from BSI's New AI Algorithm Audit and Dataset Testing Services DeepEyeVision
20-Nov-2024 KOELIS announces the first interim results of the VIOLETTE trial which evaluates the use of OBT-Fusion® technology in focal ablation of the prostate by microwave needles KOELIS
20-Nov-2024 STUDY LINKS RARE GENETIC MUTATION TO SEVERE NEUROLOGICAL DISORDER Karl Landsteiner University of Health Sciences
20-Nov-2024 Seaport Therapeutics Adds Sandi Peterson to its Board of Directors Seaport Therapeutics
20-Nov-2024 Mann Eye Institute First in Texas to Offer Revolutionary Glaucoma Treatment With Voyager DSLT AccessWire
20-Nov-2024 Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery Recursion
20-Nov-2024 Stemtech Corporation and Viago Announce Strategic Merger AccessWire
20-Nov-2024 ALL Study Groups using DehydraTECH Processing Outperform Rybelsus(R) in Body Weight Control in Lexaria’s 12-Week GLP-1, Diabetes Animal Study AccessWire
20-Nov-2024 Overcharged, Overdiagnosed, and Overwhelmed? Quizzify Teaches Patients to Take Control of Healthcare Spending AccessWire
20-Nov-2024 First Patient Dosed in Aptevo's Ongoing RAINIER Trial Achieves 90% Reduction in Leukemic Blasts Within the First 30 Days of Treatment, Continues Overall Efficacy Trend Seen in Prior Mipletamig AML Studies AccessWire
20-Nov-2024 enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium AccessWire
20-Nov-2024 Aesthetic Surgical Images Has Been Recognized in the Best of Omaha Awards AccessWire
20-Nov-2024 Novadip’s NVDX3 reaches key milestones leading to IND approval from FDA to start phase 2b/3 study in cervical spine fusion Andrew Lloyd Associates
20-Nov-2024 Leafbuyer Technologies, Inc. Announces Record Results: 38% Increase in Quarterly Revenue and 53% Increase in Gross Margins AccessWire